Event Details
The Liver Meeting 2024 - American Association for the Study of Liver Diseases (AASLD)
Nov 15 - Nov 19, 2024
Title: Long-Term Safety and Efficacy of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease Enrolled in the Phase 2 Placebo-Controlled SEQUOIA Trial
Date/Time: November 18, 2024, 8:00 am PST
Presenter: Virginia Clark
Session: Metabolic and Genetic Disease
Title: Digital Image Quantification of Collagen Proportionate Area Correlates with METAVIR Fibrosis Stage and Liver Stiffness Measurement Via FibroScan® in Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Date/Time: November 18, 2024, 8:00 am PST
Presenter: Cynthia Behling
Session: Metabolic and Genetic Disease
Title: Concordance of Histological and Liquid Chromatography Mass Spectrometry-Based Intrahepatic Z-Alpha-1 Antitrypsin (Z-AAT) Burden Assessments in Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Date/Time: November 18, 2024, 8:00 am PST
Presenter: Rohit Loomba
Session: Metabolic and Genetic Disease